No Data
Jinhe Biotechnology (002688.SZ): Recently, one invention patent certificate.
On March 18, Glonghui reported that Jinhe Biotechnology (002688.SZ) announced that it recently received an invention patent certificate issued by the National Intellectual Property Administration for the fermentation method, fermentation products, and applications of golden streptomyces fermentation yeast.
Jinhe Biotechnology (002688.SZ): Abandoning the priority right to acquire part of the minority shareholder equity of its controlled subsidiary Jinhe Pharmaceutical and increasing its capital.
On March 12, Gelonghui reported that Jinhe Biotechnology (002688.SZ) announced that the minority shareholders of its holding subsidiary Inner Mongolia Jinhe Pharmaceutical Technology Co., Ltd. (referred to as "Jinhe Pharmaceutical" or "symbol company"), including Lu Mudan, Li Fuzhong, and 11 others, plan to transfer all of their shares in Jinhe Pharmaceutical, along with part of the shares held by Zhang Hongyi, totaling 9.3 million yuan (accounting for 18.60%), to individuals Fang Jun, Xu Bing, and Guo Qilong. The company agreed to waive its right of first refusal on the partial transfer of shares in Jinhe Pharmaceutical under the same conditions. To further enhance the capital strength of Jinhe Pharmaceutical and support its business development, Jinhe Biotech...
Jinhe Biotechnology (002688.SZ): The product of aureofacient has preventive and therapeutic effects on specific animal diseases, but it does not directly target Bird Flu.
According to Gelonghui on March 6, Jinhe Biotechnology (002688.SZ) stated on the investor interaction platform that the company's Streptogramin products have preventive and therapeutic effects on certain animal diseases, but do not specifically target Bird Flu; the company is operating normally and all work is progressing smoothly.
Jinhe Biotechnology Gets Nod to Market Swine Pseudorabies Vaccine
The Five-year Loss for Jinhe Biotechnology (SZSE:002688) Shareholders Likely Driven by Its Shrinking Earnings
Overview of the lifting of restrictions on A-shares | December 30
According to Zhichun Financial APP, on December 30, a total of 37 listed companies had their restricted shares unlocked, with a total market value of approximately 12.254 billion yuan. Today's specific situation of the restricted shares unlocked is as follows: Stock Abbreviation Stock Code Restricted Stock Type Number of Stocks Unlocked Henan Yuneng Holdings 001896 Placement of A-shares for original shareholders 0.205 billion Datang Telecom Technology 600198 Placement of A-shares for original shareholders 0.428 billion China National Software & Service 600536 Stock-based Incentive restricted circulation 0.7513 million Xiamen Tungsten 600549 Stock-based Incentive restricted circulation 3.6369 million Yueyang Forest & Paper 600963 Stock-based Incentive restricted circulation 0.27 million
Some Jinhe Biotechnology CO., LTD. (SZSE:002688) Shareholders Look For Exit As Shares Take 27% Pounding
